Contineum Therapeutics, Inc. (CTNM)
NASDAQ: CTNM · Real-Time Price · USD
10.64
-0.26 (-2.39%)
At close: Nov 14, 2025, 4:00 PM EST
10.66
+0.02 (0.19%)
After-hours: Nov 14, 2025, 4:10 PM EST

Contineum Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
42.6321.9415.535.574.63
Short-Term Investments
139.77182.82109.6641.6764.37
Cash & Short-Term Investments
182.41204.76125.1947.2469
Cash Growth
-14.73%63.56%165.01%-31.54%-
Prepaid Expenses
2.521.632.521.150.78
Total Current Assets
184.93206.39127.7148.3969.78
Property, Plant & Equipment
5.656.461.42.120.64
Other Long-Term Assets
0.2701.280.130.1
Total Assets
190.85212.85130.3950.6470.52
Accounts Payable
0.791.810.640.430.66
Accrued Expenses
4.16.714.392.061.69
Current Portion of Long-Term Debt
---3.951.25
Current Portion of Leases
1.481.450.461.11-
Other Current Liabilities
----0.08
Total Current Liabilities
6.369.975.487.553.67
Long-Term Debt
----3.66
Long-Term Leases
4.024.810.110.79-
Other Long-Term Liabilities
--0.113.031.6
Total Liabilities
10.3814.785.711.378.93
Common Stock
0.030.0300.010.01
Additional Paid-In Capital
342.4315.377.14.722.74
Retained Earnings
-162.22-117.4-75.14-97.86-73.61
Comprehensive Income & Other
0.270.070.11-0.08-0.04
Total Common Equity
180.47198.07-67.94-93.21-70.89
Shareholders' Equity
180.47198.07124.6839.2761.59
Total Liabilities & Equity
190.85212.85130.3950.6470.52
Total Debt
5.496.260.575.854.91
Net Cash (Debt)
176.91198.5124.6241.3964.1
Net Cash Growth
-17.06%59.29%201.08%-35.42%-
Net Cash Per Share
6.6910.2636.7018.4530.39
Filing Date Shares Outstanding
29.1825.872.352.262.11
Total Common Shares Outstanding
29.1825.852.352.262.11
Working Capital
178.57196.41122.2240.8466.11
Book Value Per Share
6.187.66-28.91-41.25-33.61
Tangible Book Value
180.47198.07-67.94-93.21-70.89
Tangible Book Value Per Share
6.187.66-28.91-41.25-33.61
Machinery
-2.532.111.691.58
Leasehold Improvements
-0.180.050.020.02
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q